Location History:
- Jiulongpo Chongqing, CN (2013)
- Chongqing, CN (2015)
Company Filing History:
1 out of 3 
1 out of 832,912 Years Active: 2013-2015
Title: Xuefeng Ma: Innovator in Uricase Research
Introduction
Xuefeng Ma is a notable inventor based in Chongqing, China. He has made significant contributions to the field of biochemistry, particularly in the development of innovative treatments for hyperuricemia and gout. With a total of 2 patents, his work has the potential to impact many lives.
Latest Patents
Xuefeng Ma's latest patents include a PEGylated analogue protein of canine urate oxidase, which provides a preparation method and its uses. This analogue protein can be utilized for the prevention and treatment of hyperuricemia and chronic gout. Another significant patent is for a humanized recombinant uricase and its mutants, which are designed to have reduced immunogenicity in humans. This innovation also aims to treat hyperuricemia and gout effectively.
Career Highlights
Throughout his career, Xuefeng Ma has worked with various organizations, including Chongqing Fagen Biomedical Inc. His research and inventions have positioned him as a key figure in the field of uricase research.
Collaborations
Xuefeng Ma has collaborated with notable individuals such as Chun Zhang and Kai Fan. These partnerships have likely contributed to the advancement of his research and innovations.
Conclusion
Xuefeng Ma's contributions to the field of biochemistry, particularly through his patents, demonstrate his commitment to advancing medical treatments for conditions like hyperuricemia and gout. His work continues to inspire future innovations in this critical area of health.